Gene cloning of a novel cytokine inducing ICAM-1
Gene cloning of a novel cytokine inducing ICAM-1
批准号:
04670382
负责人:
MIYASAKA Nobuyuki
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1994
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The interaction between lymphoma cells and vascular endothelial cells (EC) is the first critical step in the ivasion of lymphoma cells. We found that invasive human CCRF-CEM T lymphoma cells (CEM) released a factor that upregulates the expression of adhesion molecules on vascular EC.The supernatant of CEM (CEM-SUP) increased the expression of both ICAM-1 and ELAM-1 in time- and dose-dependent manners as shown by cell enzyme-linked immunoadsobent assay (ELISA). In contrast, the induction of VCAM-1 on EC with CEM-SUP was relatively weak. No reactivity for interleukin-lalpha, interleukin-1 beta, interferon-gamma, or tumor necrosis factor alpha, which are known to augment ICAM-1 expression, was detected in CEM-SUP by ELISA.In reverse transcriptase polymerase chain reaction (RT-PCR) assay, CEM expressed a minimum amount of tumor necrosis factor alpha mRNA but absolutely no interleukin 1 beta and interferon gamma mRNA.In addition, anttibodies to cytokines did not inhibit the upregulatory effect of CEM-SUP.Semipurified CEM-SUP further increased the cellular binding between CEM cells and EC in vitro. This factor was stabel to heat (65゚C,30 min) and labile to acid (pH2). Gel filtration and chromatofocusing estimated its molecular weight at 50 with an isoelectric point of ph 7.2. Produciton of this factor might contribute the invasive charcter of cEM through upregulation of adhesion molecules on EC.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
宮坂 信之: "サイトカイン療法-up DATE(高久 央慶 編)" 南江堂, 248 (1993)
Nobuyuki Miyasaka:“细胞因子治疗-up DATE(大吉高编辑)” Nankodo,248(1993)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyasaka,N.et al.: "Augmented expression of inflammatory cytokines and sdhesion molecules in accelerated nodulosis during methotrexate therapy." Annals of the Rheumatic Diseases. 53. 480-481 (1994)
Miyasaka,N.et al.:“甲氨蝶呤治疗期间加速结节病中炎症细胞因子和粘附分子的表达增强。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Totsuka, T.et al.: "Invasive human T Iymphoma cells produce a novefactor which upregulates adhesion molecules on endothelial cells." Exp.Hematol.21. 1544-4549 (1993)
Totsuka, T.等人:“侵袭性人类 T 淋巴瘤细胞产生一种新因子,可上调内皮细胞上的粘附分子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyasaka,N.et al.: "An immunomodulatory protein,Ling-Zhi(LZ-8)facilitates cellular interaction through modulation of adhesion molecules." Biochem.Biophys.Res.Commun.,. 186. 385-390 (1992)
Miyasaka,N.et al.:“灵芝 (LZ-8) 是一种免疫调节蛋白,通过调节粘附分子促进细胞相互作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyasaka, N.et al.: "Augmented expression of inflammatory cytokines and adhesion molecules in accelerated nodulosis during methotrexated therapy." Ann.Rheum.Dis.53. 480-481 (1994)
Miyasaka, N.等人:“甲氨蝶呤治疗期间加速结节病中炎症细胞因子和粘附分子的表达增强。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
Clinical Application of Cell Cycle Control Therapy to Rheumatoid Arthritis
-
批准号:13854014
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$78.62万
-
财政年份:2001
-
负责人:MIYASAKA Nobuyuki
-
依托单位:
The role of MAdCAM-1 for induction and maintenance of oral tolerance -analysis with animal model of arthritis
-
批准号:11557037
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:MIYASAKA Nobuyuki
-
依托单位:
Cell Cycle Control for Treatment of Rheumatoid Arthritis
-
批准号:10470124
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.0万
-
财政年份:1998
-
负责人:MIYASAKA Nobuyuki
-
依托单位:
The development of the treatment of autoimmune diseases by cytokine gene transfer
-
批准号:07457122
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.54万
-
财政年份:1995
-
负责人:MIYASAKA Nobuyuki
-
依托单位:
海外基金